More than 11,000 bottles of the blood pressure medication chlorthalidone have been recalled, according to the Food and Drug Administration (FDA). Manufacturer Inventia Healthcare Limited recalled the prescription-only drug on June 5 due to “failed dissolution specifications,” meaning there’s an issue with how the tablets dissolve, which could impact their effectiveness.1

Which Medication Was Recalled?

The recalled drug can be identified with the following:

• Product description: Chlorthalidone Tablets, USP, 25 mg
• Size: 100-tablet bottle, with NDC: 64980-599-01 and batch code: RISA24001
• Size: 1,000-tablet bottle, with NDC: 64980-599-10 and batch code: ISB24002
• Expiration date: 04/2027
• Affected quantity: 11,460 bottles

What You Should Do

The FDA has yet to set a risk level for the recall or provide specific instructions for consumers. If your medication is affected, consider talking to your doctor or pharmacist to determine the best course of action.

Stopping a medication suddenly can sometimes be riskier than the reason for the recall, Jennifer Young, PharmD, BCPS, CSP, lead medication safety specialist at the Institute for Safe Medication Practices, previously told Health.

“While recall notifications can be frightening,” she said, “it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine.”